openPR Logo
Press release

Pharma valuation expert, BiopharmaVantage advises on the valuation of a pharmaceutical company developing COVID therapeutics

08-03-2021 11:22 AM CET | Health & Medicine

Press release from: BiopharmaVantage

BiopharmaVantage-Life Sciences Valuation Services - Pharma Biotech Valuation Consulting

BiopharmaVantage-Life Sciences Valuation Services - Pharma Biotech Valuation Consulting

Pharma and Biotech valuation expert, BiopharmaVantage is delighted to announce that it has advised on the valuation of an early-stage pharmaceutical company (the client) seeking investment. The early-stage company utilizes a de-risked platform for devising therapeutics for various indications, and the lead asset is an intervention for the treatment of COVID 19 patients.

The engagement lead at BiopharmaVantage commented- ‘COVID has significantly affected the products portfolio of pharmaceutical companies. The industry has swiftly devised an array of interventions - the asset whose valuation we have conducted meets the need of mild-to-moderate patients with a distinct value proposition. Our valuation service will enable the company to bring a much-needed treatment to patients.’

Katherine Mae
Business Development Manager
BiopharmaVantage, Oxford, UK

BiopharmaVantage is a healthcare consultancy that provides valuation services specifically for pharmaceutical, biotechnology, diagnostics, medtech and wider life sciences companies. If you would like to discuss how we can assist you, then please contact us.

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pharma valuation expert, BiopharmaVantage advises on the valuation of a pharmaceutical company developing COVID therapeutics here

News-ID: 2339764 • Views: 667

More Releases from BiopharmaVantage

Demystifying pharma COGS competitive intelligence
COGS, aka the cost of goods sold, is one of the key intelligence questions that frequently emerges in the pharma competitive intelligence engagements. BiopharmaVantage, the specialist pharma competitive intelligence firm, describes the issues with COGS so that end-users leverage such intelligence judiciously in their pharma intelligence collection exercises. These include: • Understanding of the meaning of COGS • Impact of method of accounts • Impact of accounting policies • Global footprint of pharma value chain • Learn from the evolving
Maximizing ROI of Pharma Competitive Intelligence
Maximizing ROI of pharmaceutical competitive intelligence engagements is vital for a variety of reasons. BiopharmaVantage, the specialist pharma competitive intelligence firm describes the key success factors that users need to focus on in order to maximize the ROI of engagements. The firm recommends the usage of the following multi-factor framework: Aren’t they well known? Collectors become defenders Consulting firm aspirants Procuring non-core services of suppliers Learn from the evolving market An agency with ex-pharma employees Intelligence collection

More Releases for Valuation

Mineral Valuation Specialists Offers a Myriad of Premium Mineral Appraisal and M …
June 28, 2018 – Mineral Valuation Specialists, devoted to meeting standards as set forth by USPAP and the mineral appraisal industry, provides highly-qualified consulting, valuation and expert services related to mining and mineral properties and businesses that can be individualized to meet the needs of their clients. Mineral Valuation Specialists also offers expert witness services and provides depositions and trial testimony, lending its expertise in this area when appropriate. “Mineral
Ultrasound Table Market Valuation 2017 – 2025
Ultrasound is an imaging technique that uses sound waves to capture images of internal body parts such as contour, size and appearance of organs, vessels and tissues or to identify abnormality such as tumors. The conventional ultrasound captures the images in flat, thin units of the body. Developments in ultrasound technology involve three-dimensional (3-D) ultrasound which modifies the sound wave data into the 3-Dimentional images. The technique is accomplished to
Toxoplasmosis Testing Market Valuation By 2021
The term toxoplasmosis refers to the infectious disease caused by the parasite Toxoplasma gondii. It may cause acute or chronic infection. Toxoplasmosis is caused by the consumption of improperly cooked mutton, pork, goat, or beef. It is also caused due to the transmission of T. gondii parasite through open wounds, contaminated raw meat, and food or dust contaminated with cat feces. These parasites are found in the kidney, bladder, and
Pretreatment Coatings Market Valuation In 2025
Global Pretreatment Coatings Market: Snapshot Thanks to the escalating sales of automobiles across the world, the global pretreatment coatings market has gain remarkable momentum. Owing to the increasing popularity of pretreatment coatings as an important initial stage for powder coatings – required for superior finish of coatings on metal surfaces that increase their shelf life – their application on metals, such as steel, galvanized steel, aluminum, copper, and zinc alloys has
Real Estate Valuation of fine art
The researcher in charge of the project “Fidel Micó Catalogue Raisonné” (FMCR) is pleased to announce relevant findings on the appraisal of 29 paintings included in the research. The generally recognized method of valuation among appraisers at auction houses is mostly based on previous auction records to obtain a something usually named “fair market value” (FMV). This value is the price that someone paid for an artwork, no matter, for
ValuSource's Express Business Valuation Voted #1 Valuation Software
QCOLORADO SPINGS, CO, March 30th, 2016 -- ValuSource, the number one leader in business valuation data and software, today announced that ValuSource's Express Business Valuation was voted winner in the Business Valuation category of the CPA Practice Advisor's annual Reader's Choice Awards. "Having been featured in the top four every year since 2009, this year we are very pleased to have won first prize," says David Fein, CEO ValuSource, KeyValueData